A synthetic version of the full 43-amino acid Thymosin Beta-4 peptide. Studied for its role in actin sequestration and cytoskeletal dynamics, it serves as a key model for research into cell migration and tissue remodeling. For research use only. Not for human consumption.
The BPC-157 and TB-500 blend pairs two extensively studied research peptides commonly examined in experimental models of cellular maintenance and tissue dynamics. BPC-157 is a 15–amino acid peptide fragment originally identified as part of a gastric body protection compound. In laboratory settings, it has been explored for its interaction with nitric oxide signaling, angiogenic mediators, and growth-related molecular pathways involved in cellular resilience.
TB-500 is a synthetic peptide derived from a functional region of Thymosin Beta-4 and is primarily studied for its influence on actin regulation and cytoskeletal organization. Research indicates that TB-500 participates in processes related to cell migration, structural organization, and tissue remodeling through modulation of actin polymerization.
When evaluated together, this peptide combination is utilized in preclinical research to investigate coordinated cellular repair mechanisms, angiogenic signaling, and molecular responses associated with tissue recovery and regenerative biology under controlled experimental conditions.
For research use only. Not for human consumption.
References
Sikiric P, et al. Current Pharmaceutical Design. 2018;24(18):2002–2030.
Goldstein AL, et al. Annals of the New York Academy of Sciences. 2007;1112:148–154.
Malinda KM, et al. FASEB Journal. 1999;13(14):2106–2114.